VIA
COLL icon

Virtus Investment Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Virtus Investment Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,446
Closed -$700K – 518
2024
Q4 		$700K Buy
24,446
+2,477
+11% +$82K 0.55% 43
2024
Q3 		$849K Buy
+21,969
New +$783K 0.67% 29
2023
Q1 		– Sell
-8,119
Closed -$188K – 288
2022
Q4 		$188K Hold
8,119
– – 0.13% 203
2022
Q3 		$130K Buy
+8,119
New +$143K 0.06% 261

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtus Investment Advisers's COLL Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 24,446 shares — an estimated $700K sold.

Virtus Investment Advisers first reported a position in COLL in Q3 2022 and held it in 4 quarters. The position peaked at $849K in Q3 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 24,446 Collegium Pharmaceutical shares in Q1 2025, an estimated $700K.
  • Virtus Investment Advisers first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 4 quarters.
  • Virtus Investment Advisers's Collegium Pharmaceutical position peaked at $849K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.